This platform randomized clinical trial examines the effectiveness ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of early mild to moderate COVID-19.
Source: JAMA Online First
| Curriculum Vitae | Résumé |
This platform randomized clinical trial examines the effectiveness ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of early mild to moderate COVID-19.
Source: JAMA Online First